Literature DB >> 30951610

Chemoenzymatic Preparation of 4'-Thioribose NAD.

Xiao-Nan Zhang1, Zhefu Dai1, Qinqin Cheng1, Yong Zhang1,2,3,4.   

Abstract

This chemoenzymatic procedure describes a strategy for the preparation of 4'-thioribose nicotinamide adenine dinucleotide (S-NAD+ ), including chemical synthesis of nicotinamide 4'-riboside (S-NR), recombinant expression and purification of two NAD+ biosynthesis enzymes nicotinamide riboside kinase (NRK) and nicotinamide mononucleotide adenylyltransferase (NMNAT), and enzymatic synthesis of S-NAD+ . The first basic protocol describes the procedures for introduction of nicotinamide onto 4'-thioribose and subsequent deprotection to generate S-NR as the key intermediate for enzymatically synthesizing S-NAD+ . In the second basic protocol, experimental methods are detailed for the production of recombinant human NRK1 and NMNAT1 to catalyze conversion of S-NR to S-NAD+ . The third basic protocol presents the enzymatic approach for the generation of S-NAD+ from S-NR precursor.
© 2019 by John Wiley & Sons, Inc. © 2019 John Wiley & Sons, Inc.

Entities:  

Keywords:  4′-thioribose; NAD+; NMNAT; NRK; chemoenzymatic synthesis; nicotinamide riboside

Mesh:

Substances:

Year:  2019        PMID: 30951610      PMCID: PMC6633912          DOI: 10.1002/cpnc.83

Source DB:  PubMed          Journal:  Curr Protoc Nucleic Acid Chem        ISSN: 1934-9270


  35 in total

1.  Identification of a novel human nicotinamide mononucleotide adenylyltransferase.

Authors:  Nadia Raffaelli; Leonardo Sorci; Adolfo Amici; Monica Emanuelli; Francesca Mazzola; Giulio Magni
Journal:  Biochem Biophys Res Commun       Date:  2002-10-04       Impact factor: 3.575

2.  Real-Time Cellular Imaging of Protein Poly(ADP-ribos)ylation.

Authors:  Annette Buntz; Sarah Wallrodt; Eva Gwosch; Michael Schmalz; Sascha Beneke; Elisa Ferrando-May; Andreas Marx; Andreas Zumbusch
Journal:  Angew Chem Int Ed Engl       Date:  2016-07-28       Impact factor: 15.336

3.  Chemical synthesis of the novel Ca2+ messenger NAADP.

Authors:  James Dowden; Richard S Brown; Christelle Moreau; Antony Galione; Barry V L Potter
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2005       Impact factor: 1.381

4.  An efficient chemical synthesis of nicotinamide riboside (NAR) and analogues.

Authors:  Shinji Tanimori; Takeshi Ohta; Mitsunori Kirihata
Journal:  Bioorg Med Chem Lett       Date:  2002-04-22       Impact factor: 2.823

5.  Transition state of ADP-ribosylation of acetyllysine catalyzed by Archaeoglobus fulgidus Sir2 determined by kinetic isotope effects and computational approaches.

Authors:  Yana Cen; Anthony A Sauve
Journal:  J Am Chem Soc       Date:  2010-09-08       Impact factor: 15.419

6.  Synthesis of carba-NAD and the structures of its ternary complexes with SIRT3 and SIRT5.

Authors:  Bruce G Szczepankiewicz; Han Dai; Karsten J Koppetsch; Dongming Qian; Fan Jiang; Cheney Mao; Robert B Perni
Journal:  J Org Chem       Date:  2012-08-17       Impact factor: 4.354

Review 7.  Nicotinamide adenine dinucleotide: beyond a redox coenzyme.

Authors:  Hening Lin
Journal:  Org Biomol Chem       Date:  2007-08-21       Impact factor: 3.876

8.  Mechanism-based small molecule probes for labeling CD38 on live cells.

Authors:  Hong Jiang; Johanna Congleton; Qun Liu; Paolomi Merchant; Fabio Malavasi; Hon Cheung Lee; Quan Hao; Andrew Yen; Hening Lin
Journal:  J Am Chem Soc       Date:  2009-02-11       Impact factor: 15.419

9.  Nicotinamide riboside kinase structures reveal new pathways to NAD+.

Authors:  Wolfram Tempel; Wael M Rabeh; Katrina L Bogan; Peter Belenky; Marzena Wojcik; Heather F Seidle; Lyudmila Nedyalkova; Tianle Yang; Anthony A Sauve; Hee-Won Park; Charles Brenner
Journal:  PLoS Biol       Date:  2007-10-02       Impact factor: 8.029

10.  NAD+ analog reveals PARP-1 substrate-blocking mechanism and allosteric communication from catalytic center to DNA-binding domains.

Authors:  Marie-France Langelier; Levani Zandarashvili; Pedro M Aguiar; Ben E Black; John M Pascal
Journal:  Nat Commun       Date:  2018-02-27       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.